Essential and secondary hypertension Flashcards

1
Q

What causes essential HPTN

A

Genetics and environment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is stage 1 HPTN clinic vs AMPB/HMPB

A

140-159/90-99
135-149/85-94 - AMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is stage 2 HPTN

A

160-179/100-119 - clinci
AMP >150/95 <180/120

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Stage 3 or severe HPTN

A

> 180/120mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Requirements for taking BP

A

Quiet room
No smoking, exercise or caffeine for 30 mins before
after 5 mins seated
Arms at chest level
3 measurements 1 min apart and average 2
Check both arms use higher reading
Check standing and sitting BP for postural HPTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What can cause postural hypotension

A

Drug induces
Autonomic neuropathy related postural hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is discrepancy between arms in BP?

A

Aortic stenosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Risk factors for modifiable HPTN

A

Salt consumption
Low intake fruit and veg
Sat fats and trans fats
Being overweight and obese
Harmful use of alcohol
Lack of physical activity
Smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Consequences HPTN

A

Heart attack
Stroke
Kidney failure
Blindness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How often should over 60s have their blood pressure monitored

A

Annually

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Investigations of patients with HPTN

A

ECG
Urinalysis
U+Es, electrolytes, eGFR, HBa1c, lipid profile
CXR or ECHO only if LVH sus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ways to decrease HPTN non phramaceutical

A

Weight loss - 2/1 per kg

DASH diet - 8/6 per kg

Substitiuting sodium chloride to potassium chloride (low salt )

Decrease alcohol

Increase fibre

Exercise moderate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When to seek immediate advice/referral for HPTN

A

Stage 3 or higher

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Drugs causing HPTN

A

Corticosteroids
COX-2 inhibitors, NSAIDs
Erythropoietin
Oral contraceptive pill
SSRIs
MAOIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Erythropoietin indications

A
  • treatment of anemia due to Chronic Kidney Disease (CKD) in patients on dialysis and not on dialysis.
  • treatment of anemia due to zidovudine in patients with HIV-infection.
  • treatment of anemia due to the effects of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy.
  • reduction of allogeneic RBC transfusions in patients undergoing elective, noncardiac, nonvascular surgery.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What two categories cause secondary HPTN

A

Renal
Endocrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Renal causes of secondary HPTN

A

Primary renal disease
Renovascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Endocrine causes of secondary HPTN

A

Mineralcorticoid excess
Catecholamine excess

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Primary renal disease causes

A

(polycsytic kidneys, chronic renal disease from diabetes, SLE et

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Renovascular disease causes

A

Fibromuscular hyperplasia if young, atherosclerosis older ppl

20
Q

Mineralcorticoid excess cuases

A

Aldestorne excess - Conns syndrome
Cortisol - cushings

21
Q

What can cause catecholamine excess

A

Phaeochromocytomas
Acromegaly
Hypoparathyroidism

22
Q

What are the macula dnsa

A

Highly metabolically active cells next to arterioles in JGM responsible for activating RAAS

23
Q

How is RAAS activated

A

Macula densa sense changes in blood flow and modify release of renin in reaction to this

24
Q

What happens in unilateral renovascular disease to plasma renin activity?

A

It is elevated

25
Q

Why does unilateral renovascular disease cause increased renin activity

A

One kidney underperfused -> RAS increased, angiotensin dependent hypertension
One overperfused outweighed, does cause increased Na excretion

26
Q

Why can RAS blocking treatment cause unilateral kidney failure in unilateral renovascular disease?

A

Underperfused kidney even less perfused with reduced BP -> eGFR failure

27
Q

Mechanism behind bilateral RA stenosis

A

Reduced overall kdiney perfusion, increased RAS, impaired Na and H20 secretion inhibits RAS, volume increase is what causes increased BP

28
Q

Plasma renin acitvity in bilateral renovascular disease

A

normal or low angiotensin (attmepting to compensate)

29
Q

Why is RAAS blockage mediation so dangerous in bilateral renovascular disease?

A

Both kidneys already readuced perfusion, if BP lowered -> AKI or significant kidney impairement

30
Q

What features would warrant further investigation for renal hypertension

A

Isolated HPTN in young women
HPTN with reduced eGFR
Resistant HPTN (3+ agents)
ACEi treat -> reduced eGFR or abnormal urinalysis with protein or haematuria
Acute pulmonary oedema with no cardiac disease
Coincidental atherosclerotic vascular disease and renal artery bruits, absent peripheral pulses

31
Q

Further investigations for renal causes of HPTN

A

Renal imaging with US nad doppler flow along renal arteries
Peripheral pulses

32
Q

Manageing primary renal disease

A

Treat underlying cause
Treat BP as per CKD guidelines if primary renal disease not treatable

33
Q

Renovascular disease management

A

AVOID RAS blocking agents
Stenting of renal artery stenosis if possible

34
Q

When do you consider mineralcorticoid excess as a cause o secondary HPTN

A

Hypokalemia (not always present)
Drug resistant HPTN (2+)
Isolated metabolic alkalosis (Na always normal, bicarb raised)

35
Q

Why get isolated hypokalemia in mineralcorticoid excess

A

Potassium reabsorption exchanged for H+ is mechanism for correcting hypokalemia -> reduced H+ in body

36
Q

Causes of mineralcorticoid excess

A

Adrenocortical adenoma (tumour-> aldosterone)
Bilateral adrenocortical hyperplasia (bilaterally -> excess aldosteroe)

37
Q

What plasma aldosterone:renin ratio is diagnostic for mineralcorticoid excess

A

> 300pmol/L

38
Q

What to do if positive aldosterone:renin ratio

A

Image renal glands with CT, US +/-selective venous sampling from adrenal veins

39
Q

Management of mineralcorticoid excess

A

Surgery - single adenoma
Spironolactone (K+ receptor blockers)

40
Q

What syndrome can present with mineralcorticoid excess

A

Cushings (metabolic alkalosis, hyperkalaemia and HPTN caused by excess cortisol)

41
Q

What are the biologically active catecholamines

A

Dopamine
Norepinephrine
Epinephrine
Secerted from adrenal medulla - autonomic

42
Q

What effect does beta receptors have when activated

A

Increase in HR and force of contraction

43
Q

What effect does alpha receptors have when activated

A

Increased venous return to heart
Increased peripheral resistance

44
Q

Phaeochromocytoma symptoms

A

BP v high fluctuates
Headaches - intermittnet, parozysmal, severe
Excess sweating
Racing heart - tachycardia, palpitations
Anxiety/nervous, impednding doom
Tremors
Pain in lower chest or upper abdomen
Nausea w/wout vomit
Weight loss
Heat intolerance
Diabetes mellitus
Posutral hypotension - autonomic overactivity

45
Q

Investigation/management phaeochromocytoma

A

Plasma or 24 hour irnary metanephries or catecholamines
Avoid beta blockers - unstopped alpha adrenergic activity
Imaging by CT (outside adrenal glands)

46
Q

Management of phaechromcytoma

A

Surgical removal best - pre op prep with alpha and beta blockers essential
May require cortisol replacement if removed

47
Q

Sites of phaechromocytomas

A

85% adrenal glands
Within sympathetic nerve chain along spinal cord
Overlying distal aorta or major vessels
Within ureters
Within urinary bladder